Edizioni

Rivista e Edizione

Volume 30 (2022): Edizione 3 (July 2022)

Volume 30 (2022): Edizione 2 (April 2022)

Volume 30 (2022): Edizione 1 (January 2022)

Volume 29 (2021): Edizione 4 (October 2021)

Volume 29 (2021): Edizione 3 (July 2021)

Volume 29 (2021): Edizione 2 (April 2021)

Volume 29 (2021): Edizione 1 (January 2021)

Volume 28 (2020): Edizione 4 (October 2020)

Volume 28 (2020): Edizione 3 (July 2020)

Volume 28 (2020): Edizione 2 (April 2020)

Volume 28 (2020): Edizione 1 (January 2020)

Volume 27 (2019): Edizione 4 (October 2019)

Volume 27 (2019): Edizione 3 (July 2019)

Volume 27 (2019): Edizione 2 (April 2019)

Volume 27 (2019): Edizione 1 (January 2019)

Volume 26 (2018): Edizione 4 (October 2018)

Volume 26 (2018): Edizione 3 (July 2018)

Volume 26 (2018): Edizione 2 (April 2018)

Volume 26 (2018): Edizione 1 (January 2018)

Volume 25 (2017): Edizione 4 (October 2017)

Volume 25 (2017): Edizione 3 (July 2017)

Volume 25 (2017): Edizione 2 (April 2017)

Volume 25 (2017): Edizione 1 (January 2017)

Volume 24 (2016): Edizione 4 (December 2016)

Volume 24 (2016): Edizione 3 (September 2016)

Volume 24 (2016): Edizione 2 (June 2016)

Volume 24 (2016): Edizione 1 (March 2016)

Volume 23 (2015): Edizione 4 (December 2015)

Volume 23 (2015): Edizione 3 (August 2015)

Volume 23 (2015): Edizione 2 (June 2015)

Volume 23 (2015): Edizione 1 (March 2015)

Volume 22 (2014): Edizione 4 (December 2014)

Volume 22 (2014): Edizione 3 (September 2014)

Volume 22 (2014): Edizione 2 (June 2014)

Volume 22 (2014): Edizione 1 (March 2014)

Volume 21 (2013): Edizione 4 (December 2013)

Volume 21 (2013): Edizione 3 (September 2013)

Volume 21 (2013): Edizione 2 (June 2013)

Volume 21 (2013): Edizione 1 (March 2013)

Dettagli della rivista
Formato
Rivista
eISSN
2284-5623
ISSN
2284-5623
Pubblicato per la prima volta
08 Aug 2013
Periodo di pubblicazione
4 volte all'anno
Lingue
Inglese

Cerca

Volume 21 (2013): Edizione 1 (March 2013)

Dettagli della rivista
Formato
Rivista
eISSN
2284-5623
ISSN
2284-5623
Pubblicato per la prima volta
08 Aug 2013
Periodo di pubblicazione
4 volte all'anno
Lingue
Inglese

Cerca

11 Articoli
Accesso libero

What about microparticles? Perspectives and practical aspects

Pubblicato online: 08 Aug 2013
Pagine: 9 - 15

Astratto

Abstract

The first description of microparticles dates back to 1967, when Wolf reported platelet membrane fragments in human plasma and called them “platelet dust”. These vesicles were later called microparticles and the knowledge about their characterization and function has advanced since then. The generation of microparticles represents a mechanism of intercellular communication, playing various roles in both physiological and pathological conditions. Besides other multiple roles in pathology such as inflammation, atherogenesis and cancer spreading, platelet-derived microparticles are involved in thrombogenesis. Tissue factor and phosphatidylserine are both exposed on the outer membrane of platelet-derived microparticles, providing catalytic procoagulant surfaces. The evaluation of microparticles may represent a possible investigation and diagnostic tool. Their enumeration and characterization is challenging and flow cytometry remains the most widely used method for the analysis of microparticles. The aim of the authors is to review the most relevant information on the main properties, mechanisms of generation, and clinical relevance of platelet-derived microparticles, since their evaluation is increasingly considered as a diagnostic biomarker.

Keywords

  • microparticles
  • haemostasis
  • flow cytometry

Cuvinte cheie

  • microparticule
  • hemostază
  • citometrie în flux
Accesso libero

Evaluation of serum hepcidin variation in patients with rheumatoid arthritis according to anemia profile and its correlation with disease activity

Pubblicato online: 08 Aug 2013
Pagine: 17 - 27

Astratto

Abstract

Objective: The objectives of this study were: determination of serum hepcidin levels in patients with Rheumatoid arthritis (RA) with/without anemia and controls, and its correlation with disease activity and anemia parameters. Patients and Methods: 69 people were involved in our study: 54 patients and 15 healthy subjects (controls). Laboratory evaluation of anemia, iron parameters, serum hepcidin levels and disease activity was carried out. RA patients were divided in two groups: anemic group and non-anemic group (NA), according to hemoglobin levels (Hb). Soluble transferrin receptor-ferritin index (sTfR-F index) was used to classify anemia types: anemia of chronic disease (ACD) and anemia of chronic disease + iron deficiency anemia (ACD+IDA). Disease activity was evaluated using the following parameters: erythrocyte sedimentation rate (ESR), C-reactive protein (CPR), and disease activity score (DAS28). Results: ACD and ACD+IDA groups had significantly higher serum hepcidin concentrations than controls (p<0.001, p<0.001), and NA group (p=0.006, p=0.002). No difference in hepcidin levels was observed between ACD and ADC+IDA groups (p=0.85) and between NA and controls (p=0.66). ESR was significantly higher in ACD and ACD+IDA groups compared with NA group (p<0.001, p=0.002) and controls. (p<0.001, p<0.001).DAS 28 score was higher in anemic groups than NA group (ACD vs. NA, p=0.01), (ACD+IDA vs. NA, p=0.01) and no difference was observed between ACD and ACD+IDA In RA patients serum hepcidin concentration was significantly negatively correlated with hemoglobin (Hb) (r= -0.459, p<0.000) and serum iron( r=-0.357, p<0.01) and positively with disease activity variables: ESR (r=0.352, p<0.01) , CRP (r=0.369, p<0.01), DAS28 score (r=0.289, p<0.05). Conclusion: Hepcidin increases in RA patients with anemia and its levels correlate with Hb, serum iron, and disease activity variables.

Keywords

  • hepcidin
  • anemia of chronic disease
  • rheumatoid arthritis
  • DAS28
  • C reactive protein
  • erythrocyte sedimentation rate
  • soluble transferring receptor

Cuvinte cheie

  • hepcidină
  • anemia secundară bolilor comice
  • anemie feriprivă
  • poliatrită reumatoidă
  • DAS 28
Accesso libero

Tyrosine kinase inhibitor treatment outcome in a single center cohort of chronic myeloid leukemia patients. The role of the T315I ABL kinase domain mutation

Pubblicato online: 08 Aug 2013
Pagine: 29 - 37

Astratto

Abstract

Introduction. Since the introduction of the tyrosine kinase inhibitor (TKI) imatinib mesylate (IM) in the treatment of chronic myeloid leukemia (CML), a dramatic improvement in hematologic, cytogenetic and molecular responses was noted. Also, the overall survival increased significantly. Unfortunately, in certain patients, resistance to TKI develops relatively early, especially due to point mutations in the ABL kinase domain, among which the T315I mutation confers resistance to all three currently available TKIs (imatinib, dasatinib, nilotinib). Methods. We performed a prospective study on 74 patients diagnosed with chronic phase CML, for whom we analyzed the T315I mutation. Mutational analysis was performed using ARMS-PCR (with subsequent confirmation by direct sequencing) at regular intervals of 6 months or in case of suboptimal response, loss of response or progression. Correlations between the T315I mutation and disease characteristics, response to treatment and survival were analyzed. A comparative analysis between patients positive and negative for the mutation was performed. The patients were followed and evaluated according to European Leukemia Net (ELN) criteria. Results. T315I mutation was detected in 3 patients (4.05%) and its presence was correlated with younger age at diagnosis, second line TKI therapy, progressive disease and decreased survival from the moment of detection. Conclusions. ARMS-PCR is a sensitive, easy to use method for the detection of T315I mutation in chronic phase CML patients

Keywords

  • Chronic myeloid leukemia
  • mutation
  • T315I
  • imatinib

Cuvinte cheie

  • leucemie mieloidă cronică
  • mutaţie
  • T315I
  • imatinib
Accesso libero

Determining hemoglobin reference values in children and teenagers from Sibiu area

Pubblicato online: 08 Aug 2013
Pagine: 39 - 45

Astratto

Abstract

Objectives: Reference values are fundamental for the interpretation of laboratory results, which are useful for medical decisions. Each laboratory has to have its own reference values classified according to age groups in order to interpret test results correctly. The expression “normal values” has been replaced by “reference values” because there are various variables that are considered to influence these values. The majority of “reference values” were established over two decades ago using obsolete medical devices and in many cases undefined populations; therefore, nowadays these intervals are not relevant anymore for modern testing technology in clinic laboratories. Methods and materials: The study was carried out at Sibiu Clinic Pediatric Hospital using the laboratory’s electronic archive. The samples were taken from hospitalized patients (children and teenagers) and outpatients registered between January and December, 2010. Blood sample testing was performed using the Sysmex XS 1000i analyzer. The reference values for hemoglobin was calculated based on results from a population sample of 9838 patients. The patients were classified into 3 age categories: 1 month - 2 years old; 2 - 10 years old; 10 - 18 years old. Reference values were determined after eliminating outliers,using the robust method to calculate 2.5 and 97.5 percentiles with the SPSS statistical software. Results and Conclusions: The results obtained differed from those specified in the Roche Diagnostics 2004 Guide but were found to be close to the results mentioned in Lothar Thomas’s publication, in Laboratory diagnostics.

Keywords

  • children
  • teenagers
  • hemoglobin
  • reference values

Cuvinte cheie

  • copii
  • adolescenţi
  • hemoglobina
  • intervale de referinţă
Accesso libero

Infant acute leukemia with lineage switch at relapse expressing a novel t(4;11)(q21;q23) MLL-AF4 fusion transcript

Pubblicato online: 08 Aug 2013
Pagine: 47 - 58

Astratto

Abstract

Background. A high occurrence of translocation t(4;11)(q21;q23) was reported in infant acute lymphoblastic leukemia (ALL) leading to the fusion of the mixed lineage leukemia (MLL) gene on chromosome 11 and the AF4 gene on chromosome 4. More than 50 distinct MLL-AF4 types of fusion have been previously identified, none of those reported matching the peculiarities found in an infant ALL case to be reported below. Materials and methods. Molecular tests were performed for the detection of TEL-AML1, BCR-ABL(p190), E2A-PBX1, and MLL-AF4 in the peripheral blood sample of a 21 days new-born boy suspected of ALL. An unexpected MLL-AF4 fragment was identified, further purified, and later analyzed by sequencing. Flow cytometry analyses were carried out at diagnosis and relapse on a FACSCanto-II cytometer (Becton-Dickinson). Results. The patient was found to be positive for the MLL-AF4 transcript, with an uncommonly long-sized product and a previously undescribed sequence (in-frame fusion between exon 12 of MLL and exon 4 of the AF4 gene). The immunophenotypic analyses also showed a particular development: while at diagnosis a dominant malignant clone displaying a B lymphoid precursor phenotype was described, at relapse a malignant monocytoid population predominantly expanded. The presence of MLL-AF4 e12-e4 transcript was still manifest at relapse, without other transcript characteristic for myeloid lineage. Conclusions. To our knowledge, this is the first report of a MLL-AF4 rearrangement revealing this complex transcript with new breakpoints in MLL. Its early detection may predict an immunophenotypic switch and may assist the clinicians in designing optimized therapies.

Keywords

  • acute lymphoid leukemia
  • fusion proteins
  • immunophenotypic switch

Cuvinte cheie

  • leucemie acută limfatică
  • proteine de fuziune
  • switch imunofenotipic
Accesso libero

Molecular characterization of complex chromosomal changes in de novo acute myeloid leukemia: a case report

Pubblicato online: 08 Aug 2013
Pagine: 59 - 65

Astratto

Abstract

De novo acute myeloid leukemias (AML) represent a heterogeneous group of clonal hematopoietic disorders in which chromosomal abnormalities are detected in a majority of patients. At present, cytogenetic changes are recognized as important diagnostic markers and prognosis determinants. Complex karyotype changes are associated with resistance to treatment and unfavorable evolution. We report on an AML case with complex karyotype changes characterized by molecular genetic techniques (fluorescence in situ hybridization - FISH and array-based comparative genomic hybridization - array-CGH) and an extremely poor outcome. A 72 year-old female patient was admitted for genetic investigations with a clinical diagnosis of AML. Classical and molecular cytogenetic tests as well as array-CGH were performed. Complex chromosomal abnormalities were identified at diagnosis, consisting of genomic imbalances involving chromosomes 6, 7, 9, and 17. AML with complex karyotype changes is a heterogeneous disease, as a variety of genomic abnormalities are detected, involving virtually all chromosomes. The pathogenesis of AML with complex karyotype is poorly understood. The complexity of karyotypic changes in our case highlights the importance of using complementary genetic investigation in order to obtain a comprehensive view of AML genome.

Keywords

  • acute myeloid leukemia
  • array-based comparative genomic hybridization
  • complex karyotype

Cuvinte cheie

  • leucemie mieloidă acută
  • hibridizare comparativă genomică bazată pe microarray
  • mo- dificări cromozomiale complexe
Accesso libero

Carcinosarcoma of the breast with massive osseous malignant component: a basal-like entity with myoepithelial differentiation

Pubblicato online: 08 Aug 2013
Pagine: 67 - 73

Astratto

Abstract

We present the case of a 77 year old patient with a primary breast carcinosarcoma composed mostly of an osteogenic sarcoma of fibroblastic type in which only immunohistochemical analysis disclosed the presence of a minor malignant epithelial component. The malignant mesenchymal component derives from dedifferentiation of myoepithelial cells since myoepithelial markers are positive. Also, like the majority of the other metaplastic carcinomas in the breast, carcinosarcoma is a basal type of tumor that will not respond to endocrine drugs or Her2/neu therapy.

Keywords

  • carcinosarcoma
  • osseous differentiation
  • basal-like
  • myoepithelial differentiation

Cuvinte cheie

  • carcinosarcom
  • diferenţiere osoasă
  • basal-like
  • diferenţiere mioepitelială
Accesso libero

Study regarding the use of salivary 8-hydroxideoxyguanosine and Interleukin-1 gene polymorphism - as potential biomarkers in the diagnosis of aggressive periodontitis

Pubblicato online: 08 Aug 2013
Pagine: 75 - 82

Astratto

Abstract

The aim of the present study is to explore the use of salivary 8-hydroxideoxyguanosine (8-OHdG) and Interleukin-1 (IL-1) gene polymorphism in the diagnosis of the patients with aggressive periodontitis. The correlation between salivary 8-OHdG level and clinical parameters was analyzed, at the same time as the use of 8- OHdG level and IL-1gene polymorphism in patients with aggressive periodontitis. Eighteen patients suffering from aggressive periodontitis and 18 healthy subjects without any sign of periodontitis were enrolled into the study after clinical examination. The analysis of genetic polymorphism of IL-1 gene was carried out from oral swabs by using the GenoType IL-1 test; the 8-OHdG biomarker was quantified from saliva samples by using an ELISA competition test. The salivary level of 8-OHdG in the control group was 0.70±0.54 ng/mL and in aggressive periodontitis, 6.93±2.90 ng/mL (p<0.001). A positive genotype consisting of allele 2 (Thymine/Thymine) was found with lower prevalence in healthy subjects - 5.56% - when compared to aggressive periodontitis, respectively 72.22 % (p<0.001). Our study demonstrated that the salivary level of the 8-OHdG biomarker and IL-1 gene polymorphism can be used in the evaluation of the oro-dental status at patients with aggressive periodontitis

Keywords

  • 8-OHdG
  • IL-1
  • saliva
  • periodontitis

Cuvinte cheie

  • 8-OHdG
  • IL-1
  • salivă
  • parodontită
Accesso libero

Risk for metabolic syndrome in a group of overweight children from South-East Romania

Pubblicato online: 08 Aug 2013
Pagine: 83 - 92

Astratto

Abstract

The present study aims to identify and analyse the cardiometabolic risk factors associated with the metabolic syndrome in overweight children and adolescents. The study group included 163 overweight children and adolescents, average age: 13.02 ± 3.42 years. The following evaluations were performed: anthropometrical measurements, blood pressure measurements, biochemical tests investigating the lipid and carbohydrate metabolism. Metabolic syndrome was identified in 48 subjects (29.4%). The risk to develop MS was found to be higher in males and within the 13-18 age group. The most common cardiometabolic risk factors were abdominal obesity (75.5%) and high blood pressure (41.1%), followed by low HDL-cholesterol (35%), increased fasting blood glucose (23.3%) and hypertriglyceridemia (17.8%.). The variables under analysis exhibited significant correlations with the number of metabolic syndrome diagnosis criteria. The metabolic syndrome prevalence in the paediatric population affected by excess body weight has reached high values in our geographical area. It is thus justified to initiate screening activities for the early detection and adequate treatment of the modifiable cardiometabolic risk factors, contributing to the prevention of long-term complications.

Keywords

  • overweight children
  • hypertension
  • dyslipidemia
  • metabolic syndrome

Cuvinte cheie

  • obezitate abdominală
  • copii
  • hipertensiune arterială
  • dislipidemie
  • sindrom metabolic
Accesso libero

Inhibition of Streptococcus pneumoniae adenylate kinase by some 5-arylidene-thiazolidin-4-on-2-thione derivates

Pubblicato online: 08 Aug 2013
Pagine: 93 - 99

Astratto

Abstract

Adenylat kinase is an ubiquitous enzyme found in prokaryotes and eukaryotes. In the present study we examined the inhibition of Streptococcus pneumoniae adenylate kinase (AKSP) by six 5-arylidene-thiazolidin-4- on-2-thione derivates using 2, 4-dinitrophenylhydrazine colorimetric assay. Inhibition of AKSP activity with synthetic compounds was performed against recombinant enzyme over-expressed in E. coli. The compound C10H6BrNOS2 with the bromine atom in -ortho position has shown the most efficient inhibitory activity; I50 value (the inhibitor concentration that leads to 50% activity inhibition) was 0.067mM.

Keywords

  • adenylate kinase
  • 5-arylidene-thiazolidin-4-on-2-thione derivates
  • inhibitory activity

Cuvinte cheie

  • adenilat kinaza
  • 5-ariliden-tiazolidin-4-on-2-tione
  • acţiune inhibitorie
Accesso libero

The serum level of the immunomodulatory peptide cathelicidin LL37 and T helper cell type 1 inflammatory response in viral hepatitis B, C, and D

Pubblicato online: 08 Aug 2013
Pagine: 101 - 110

Astratto

Abstract

Cathelicidin LL37 is an innate immunity antimicrobial peptide involved in the immune modulation of IFN-Abstract Cathelicidin LL37 is an innate immunity antimicrobial peptide involved in the immune modulation of IFN-γ, the key cytokine of T helper cell type 1 (Th1) response. The role of LL37 in viral hepatitis inflammation is unknown. We assessed the serum variations of LL37 and the Th1 response in hepatitis C virus (HCV), hepatitis B virus (HBV) and hepatitis D virus (HDV) infections. The LL37 level (Elisa detection) and Th1 response (defined by IFN-γ level, CD4+ and CD8+ T cell count) were analyzed in 87 patients: 65 hepatitis patients (34 HCV, 18 HBV, 13 HDV) and 22 healthy controls. The subjects, 33 males/ 54 women aged 20-64 years, were selected at "Matei Bals" Institut, Bucharest, Romania. Hepatitis patients were classified according to viral etiology and viral replication as active cases (detectable viremia) versus negative cases (undetectable viremia). Student T test and Mann Whitney analysis were applied. High levels of LL37 (138.09±88.45ng/ml, p=0.045) and IFN-γ (69.82 pg/ml, p=0.005) were detected in the whole group of hepatitis. Active HCV hepatitis presented a significant increase in LL37 level (155.15±78.84ng/ml, p=0.014) and Th1 response by comparison with inactive HCV hepatitis. Conversely active HBV patients displayed low LL37 levels (76.75ng/ml, p=0.009) and no Th1 dominant response by comparison with inactive B hepatitis. High levels of LL37 up to 171.01±72.08 ng/ml and a moderate Th1 response defined HDV patients. Our results highlights increased levels of the cathelicidin LL37 in all viral hepatitis correlated with a strong and concordant immune response in active HCV hepatitis. , the key cytokine of T helper cell type 1 (Th1) response. The role of LL37 in viral hepatitis inflammation is unknown. We assessed the serum variations of LL37 and the Th1 response in hepatitis C virus (HCV), hepatitis B virus (HBV) and hepatitis D virus (HDV) infections. The LL37 level (Elisa detection) and Th1 response (defined by IFN-γ level, CD4+ and CD8+ T cell count) were analyzed in 87 patients: 65 hepatitis patients (34 HCV, 18 HBV, 13 HDV) and 22 healthy controls. The subjects, 33 males/ 54 women aged 20-64 years, were selected at "Matei Bals" Institut, Bucharest, Romania. Hepatitis patients were classified according to viral etiology and viral replication as active cases (detectable viremia) versus negative cases (undetectable viremia). Student T test and Mann Whitney analysis were applied. High levels of LL37 (138.09±88.45ng/ml, p=0.045) and IFN-γ (69.82 pg/ml, p=0.005) were detected in the whole group of hepatitis. Active HCV hepatitis presented a significant increase in LL37 level (155.15±78.84ng/ml, p=0.014) and Th1 response by comparison with inactive HCV hepatitis. Conversely active HBV patients displayed low LL37 levels (76.75ng/ml, p=0.009) and no Th1 dominant response by comparison with inactive B hepatitis. High levels of LL37 up to 171.01±72.08 ng/ml and a moderate Th1 response defined HDV patients. Our results highlights increased levels of the cathelicidin LL37 in all viral hepatitis correlated with a strong and concordant immune response in active HCV hepatitis.

Keywords

  • Cathelicidine LL37
  • Th1 response
  • viral hepatitis

Cuvinte cheie

  • Cathelicidina LL37
  • răspuns Thl
  • hepatite virale
11 Articoli
Accesso libero

What about microparticles? Perspectives and practical aspects

Pubblicato online: 08 Aug 2013
Pagine: 9 - 15

Astratto

Abstract

The first description of microparticles dates back to 1967, when Wolf reported platelet membrane fragments in human plasma and called them “platelet dust”. These vesicles were later called microparticles and the knowledge about their characterization and function has advanced since then. The generation of microparticles represents a mechanism of intercellular communication, playing various roles in both physiological and pathological conditions. Besides other multiple roles in pathology such as inflammation, atherogenesis and cancer spreading, platelet-derived microparticles are involved in thrombogenesis. Tissue factor and phosphatidylserine are both exposed on the outer membrane of platelet-derived microparticles, providing catalytic procoagulant surfaces. The evaluation of microparticles may represent a possible investigation and diagnostic tool. Their enumeration and characterization is challenging and flow cytometry remains the most widely used method for the analysis of microparticles. The aim of the authors is to review the most relevant information on the main properties, mechanisms of generation, and clinical relevance of platelet-derived microparticles, since their evaluation is increasingly considered as a diagnostic biomarker.

Keywords

  • microparticles
  • haemostasis
  • flow cytometry

Cuvinte cheie

  • microparticule
  • hemostază
  • citometrie în flux
Accesso libero

Evaluation of serum hepcidin variation in patients with rheumatoid arthritis according to anemia profile and its correlation with disease activity

Pubblicato online: 08 Aug 2013
Pagine: 17 - 27

Astratto

Abstract

Objective: The objectives of this study were: determination of serum hepcidin levels in patients with Rheumatoid arthritis (RA) with/without anemia and controls, and its correlation with disease activity and anemia parameters. Patients and Methods: 69 people were involved in our study: 54 patients and 15 healthy subjects (controls). Laboratory evaluation of anemia, iron parameters, serum hepcidin levels and disease activity was carried out. RA patients were divided in two groups: anemic group and non-anemic group (NA), according to hemoglobin levels (Hb). Soluble transferrin receptor-ferritin index (sTfR-F index) was used to classify anemia types: anemia of chronic disease (ACD) and anemia of chronic disease + iron deficiency anemia (ACD+IDA). Disease activity was evaluated using the following parameters: erythrocyte sedimentation rate (ESR), C-reactive protein (CPR), and disease activity score (DAS28). Results: ACD and ACD+IDA groups had significantly higher serum hepcidin concentrations than controls (p<0.001, p<0.001), and NA group (p=0.006, p=0.002). No difference in hepcidin levels was observed between ACD and ADC+IDA groups (p=0.85) and between NA and controls (p=0.66). ESR was significantly higher in ACD and ACD+IDA groups compared with NA group (p<0.001, p=0.002) and controls. (p<0.001, p<0.001).DAS 28 score was higher in anemic groups than NA group (ACD vs. NA, p=0.01), (ACD+IDA vs. NA, p=0.01) and no difference was observed between ACD and ACD+IDA In RA patients serum hepcidin concentration was significantly negatively correlated with hemoglobin (Hb) (r= -0.459, p<0.000) and serum iron( r=-0.357, p<0.01) and positively with disease activity variables: ESR (r=0.352, p<0.01) , CRP (r=0.369, p<0.01), DAS28 score (r=0.289, p<0.05). Conclusion: Hepcidin increases in RA patients with anemia and its levels correlate with Hb, serum iron, and disease activity variables.

Keywords

  • hepcidin
  • anemia of chronic disease
  • rheumatoid arthritis
  • DAS28
  • C reactive protein
  • erythrocyte sedimentation rate
  • soluble transferring receptor

Cuvinte cheie

  • hepcidină
  • anemia secundară bolilor comice
  • anemie feriprivă
  • poliatrită reumatoidă
  • DAS 28
Accesso libero

Tyrosine kinase inhibitor treatment outcome in a single center cohort of chronic myeloid leukemia patients. The role of the T315I ABL kinase domain mutation

Pubblicato online: 08 Aug 2013
Pagine: 29 - 37

Astratto

Abstract

Introduction. Since the introduction of the tyrosine kinase inhibitor (TKI) imatinib mesylate (IM) in the treatment of chronic myeloid leukemia (CML), a dramatic improvement in hematologic, cytogenetic and molecular responses was noted. Also, the overall survival increased significantly. Unfortunately, in certain patients, resistance to TKI develops relatively early, especially due to point mutations in the ABL kinase domain, among which the T315I mutation confers resistance to all three currently available TKIs (imatinib, dasatinib, nilotinib). Methods. We performed a prospective study on 74 patients diagnosed with chronic phase CML, for whom we analyzed the T315I mutation. Mutational analysis was performed using ARMS-PCR (with subsequent confirmation by direct sequencing) at regular intervals of 6 months or in case of suboptimal response, loss of response or progression. Correlations between the T315I mutation and disease characteristics, response to treatment and survival were analyzed. A comparative analysis between patients positive and negative for the mutation was performed. The patients were followed and evaluated according to European Leukemia Net (ELN) criteria. Results. T315I mutation was detected in 3 patients (4.05%) and its presence was correlated with younger age at diagnosis, second line TKI therapy, progressive disease and decreased survival from the moment of detection. Conclusions. ARMS-PCR is a sensitive, easy to use method for the detection of T315I mutation in chronic phase CML patients

Keywords

  • Chronic myeloid leukemia
  • mutation
  • T315I
  • imatinib

Cuvinte cheie

  • leucemie mieloidă cronică
  • mutaţie
  • T315I
  • imatinib
Accesso libero

Determining hemoglobin reference values in children and teenagers from Sibiu area

Pubblicato online: 08 Aug 2013
Pagine: 39 - 45

Astratto

Abstract

Objectives: Reference values are fundamental for the interpretation of laboratory results, which are useful for medical decisions. Each laboratory has to have its own reference values classified according to age groups in order to interpret test results correctly. The expression “normal values” has been replaced by “reference values” because there are various variables that are considered to influence these values. The majority of “reference values” were established over two decades ago using obsolete medical devices and in many cases undefined populations; therefore, nowadays these intervals are not relevant anymore for modern testing technology in clinic laboratories. Methods and materials: The study was carried out at Sibiu Clinic Pediatric Hospital using the laboratory’s electronic archive. The samples were taken from hospitalized patients (children and teenagers) and outpatients registered between January and December, 2010. Blood sample testing was performed using the Sysmex XS 1000i analyzer. The reference values for hemoglobin was calculated based on results from a population sample of 9838 patients. The patients were classified into 3 age categories: 1 month - 2 years old; 2 - 10 years old; 10 - 18 years old. Reference values were determined after eliminating outliers,using the robust method to calculate 2.5 and 97.5 percentiles with the SPSS statistical software. Results and Conclusions: The results obtained differed from those specified in the Roche Diagnostics 2004 Guide but were found to be close to the results mentioned in Lothar Thomas’s publication, in Laboratory diagnostics.

Keywords

  • children
  • teenagers
  • hemoglobin
  • reference values

Cuvinte cheie

  • copii
  • adolescenţi
  • hemoglobina
  • intervale de referinţă
Accesso libero

Infant acute leukemia with lineage switch at relapse expressing a novel t(4;11)(q21;q23) MLL-AF4 fusion transcript

Pubblicato online: 08 Aug 2013
Pagine: 47 - 58

Astratto

Abstract

Background. A high occurrence of translocation t(4;11)(q21;q23) was reported in infant acute lymphoblastic leukemia (ALL) leading to the fusion of the mixed lineage leukemia (MLL) gene on chromosome 11 and the AF4 gene on chromosome 4. More than 50 distinct MLL-AF4 types of fusion have been previously identified, none of those reported matching the peculiarities found in an infant ALL case to be reported below. Materials and methods. Molecular tests were performed for the detection of TEL-AML1, BCR-ABL(p190), E2A-PBX1, and MLL-AF4 in the peripheral blood sample of a 21 days new-born boy suspected of ALL. An unexpected MLL-AF4 fragment was identified, further purified, and later analyzed by sequencing. Flow cytometry analyses were carried out at diagnosis and relapse on a FACSCanto-II cytometer (Becton-Dickinson). Results. The patient was found to be positive for the MLL-AF4 transcript, with an uncommonly long-sized product and a previously undescribed sequence (in-frame fusion between exon 12 of MLL and exon 4 of the AF4 gene). The immunophenotypic analyses also showed a particular development: while at diagnosis a dominant malignant clone displaying a B lymphoid precursor phenotype was described, at relapse a malignant monocytoid population predominantly expanded. The presence of MLL-AF4 e12-e4 transcript was still manifest at relapse, without other transcript characteristic for myeloid lineage. Conclusions. To our knowledge, this is the first report of a MLL-AF4 rearrangement revealing this complex transcript with new breakpoints in MLL. Its early detection may predict an immunophenotypic switch and may assist the clinicians in designing optimized therapies.

Keywords

  • acute lymphoid leukemia
  • fusion proteins
  • immunophenotypic switch

Cuvinte cheie

  • leucemie acută limfatică
  • proteine de fuziune
  • switch imunofenotipic
Accesso libero

Molecular characterization of complex chromosomal changes in de novo acute myeloid leukemia: a case report

Pubblicato online: 08 Aug 2013
Pagine: 59 - 65

Astratto

Abstract

De novo acute myeloid leukemias (AML) represent a heterogeneous group of clonal hematopoietic disorders in which chromosomal abnormalities are detected in a majority of patients. At present, cytogenetic changes are recognized as important diagnostic markers and prognosis determinants. Complex karyotype changes are associated with resistance to treatment and unfavorable evolution. We report on an AML case with complex karyotype changes characterized by molecular genetic techniques (fluorescence in situ hybridization - FISH and array-based comparative genomic hybridization - array-CGH) and an extremely poor outcome. A 72 year-old female patient was admitted for genetic investigations with a clinical diagnosis of AML. Classical and molecular cytogenetic tests as well as array-CGH were performed. Complex chromosomal abnormalities were identified at diagnosis, consisting of genomic imbalances involving chromosomes 6, 7, 9, and 17. AML with complex karyotype changes is a heterogeneous disease, as a variety of genomic abnormalities are detected, involving virtually all chromosomes. The pathogenesis of AML with complex karyotype is poorly understood. The complexity of karyotypic changes in our case highlights the importance of using complementary genetic investigation in order to obtain a comprehensive view of AML genome.

Keywords

  • acute myeloid leukemia
  • array-based comparative genomic hybridization
  • complex karyotype

Cuvinte cheie

  • leucemie mieloidă acută
  • hibridizare comparativă genomică bazată pe microarray
  • mo- dificări cromozomiale complexe
Accesso libero

Carcinosarcoma of the breast with massive osseous malignant component: a basal-like entity with myoepithelial differentiation

Pubblicato online: 08 Aug 2013
Pagine: 67 - 73

Astratto

Abstract

We present the case of a 77 year old patient with a primary breast carcinosarcoma composed mostly of an osteogenic sarcoma of fibroblastic type in which only immunohistochemical analysis disclosed the presence of a minor malignant epithelial component. The malignant mesenchymal component derives from dedifferentiation of myoepithelial cells since myoepithelial markers are positive. Also, like the majority of the other metaplastic carcinomas in the breast, carcinosarcoma is a basal type of tumor that will not respond to endocrine drugs or Her2/neu therapy.

Keywords

  • carcinosarcoma
  • osseous differentiation
  • basal-like
  • myoepithelial differentiation

Cuvinte cheie

  • carcinosarcom
  • diferenţiere osoasă
  • basal-like
  • diferenţiere mioepitelială
Accesso libero

Study regarding the use of salivary 8-hydroxideoxyguanosine and Interleukin-1 gene polymorphism - as potential biomarkers in the diagnosis of aggressive periodontitis

Pubblicato online: 08 Aug 2013
Pagine: 75 - 82

Astratto

Abstract

The aim of the present study is to explore the use of salivary 8-hydroxideoxyguanosine (8-OHdG) and Interleukin-1 (IL-1) gene polymorphism in the diagnosis of the patients with aggressive periodontitis. The correlation between salivary 8-OHdG level and clinical parameters was analyzed, at the same time as the use of 8- OHdG level and IL-1gene polymorphism in patients with aggressive periodontitis. Eighteen patients suffering from aggressive periodontitis and 18 healthy subjects without any sign of periodontitis were enrolled into the study after clinical examination. The analysis of genetic polymorphism of IL-1 gene was carried out from oral swabs by using the GenoType IL-1 test; the 8-OHdG biomarker was quantified from saliva samples by using an ELISA competition test. The salivary level of 8-OHdG in the control group was 0.70±0.54 ng/mL and in aggressive periodontitis, 6.93±2.90 ng/mL (p<0.001). A positive genotype consisting of allele 2 (Thymine/Thymine) was found with lower prevalence in healthy subjects - 5.56% - when compared to aggressive periodontitis, respectively 72.22 % (p<0.001). Our study demonstrated that the salivary level of the 8-OHdG biomarker and IL-1 gene polymorphism can be used in the evaluation of the oro-dental status at patients with aggressive periodontitis

Keywords

  • 8-OHdG
  • IL-1
  • saliva
  • periodontitis

Cuvinte cheie

  • 8-OHdG
  • IL-1
  • salivă
  • parodontită
Accesso libero

Risk for metabolic syndrome in a group of overweight children from South-East Romania

Pubblicato online: 08 Aug 2013
Pagine: 83 - 92

Astratto

Abstract

The present study aims to identify and analyse the cardiometabolic risk factors associated with the metabolic syndrome in overweight children and adolescents. The study group included 163 overweight children and adolescents, average age: 13.02 ± 3.42 years. The following evaluations were performed: anthropometrical measurements, blood pressure measurements, biochemical tests investigating the lipid and carbohydrate metabolism. Metabolic syndrome was identified in 48 subjects (29.4%). The risk to develop MS was found to be higher in males and within the 13-18 age group. The most common cardiometabolic risk factors were abdominal obesity (75.5%) and high blood pressure (41.1%), followed by low HDL-cholesterol (35%), increased fasting blood glucose (23.3%) and hypertriglyceridemia (17.8%.). The variables under analysis exhibited significant correlations with the number of metabolic syndrome diagnosis criteria. The metabolic syndrome prevalence in the paediatric population affected by excess body weight has reached high values in our geographical area. It is thus justified to initiate screening activities for the early detection and adequate treatment of the modifiable cardiometabolic risk factors, contributing to the prevention of long-term complications.

Keywords

  • overweight children
  • hypertension
  • dyslipidemia
  • metabolic syndrome

Cuvinte cheie

  • obezitate abdominală
  • copii
  • hipertensiune arterială
  • dislipidemie
  • sindrom metabolic
Accesso libero

Inhibition of Streptococcus pneumoniae adenylate kinase by some 5-arylidene-thiazolidin-4-on-2-thione derivates

Pubblicato online: 08 Aug 2013
Pagine: 93 - 99

Astratto

Abstract

Adenylat kinase is an ubiquitous enzyme found in prokaryotes and eukaryotes. In the present study we examined the inhibition of Streptococcus pneumoniae adenylate kinase (AKSP) by six 5-arylidene-thiazolidin-4- on-2-thione derivates using 2, 4-dinitrophenylhydrazine colorimetric assay. Inhibition of AKSP activity with synthetic compounds was performed against recombinant enzyme over-expressed in E. coli. The compound C10H6BrNOS2 with the bromine atom in -ortho position has shown the most efficient inhibitory activity; I50 value (the inhibitor concentration that leads to 50% activity inhibition) was 0.067mM.

Keywords

  • adenylate kinase
  • 5-arylidene-thiazolidin-4-on-2-thione derivates
  • inhibitory activity

Cuvinte cheie

  • adenilat kinaza
  • 5-ariliden-tiazolidin-4-on-2-tione
  • acţiune inhibitorie
Accesso libero

The serum level of the immunomodulatory peptide cathelicidin LL37 and T helper cell type 1 inflammatory response in viral hepatitis B, C, and D

Pubblicato online: 08 Aug 2013
Pagine: 101 - 110

Astratto

Abstract

Cathelicidin LL37 is an innate immunity antimicrobial peptide involved in the immune modulation of IFN-Abstract Cathelicidin LL37 is an innate immunity antimicrobial peptide involved in the immune modulation of IFN-γ, the key cytokine of T helper cell type 1 (Th1) response. The role of LL37 in viral hepatitis inflammation is unknown. We assessed the serum variations of LL37 and the Th1 response in hepatitis C virus (HCV), hepatitis B virus (HBV) and hepatitis D virus (HDV) infections. The LL37 level (Elisa detection) and Th1 response (defined by IFN-γ level, CD4+ and CD8+ T cell count) were analyzed in 87 patients: 65 hepatitis patients (34 HCV, 18 HBV, 13 HDV) and 22 healthy controls. The subjects, 33 males/ 54 women aged 20-64 years, were selected at "Matei Bals" Institut, Bucharest, Romania. Hepatitis patients were classified according to viral etiology and viral replication as active cases (detectable viremia) versus negative cases (undetectable viremia). Student T test and Mann Whitney analysis were applied. High levels of LL37 (138.09±88.45ng/ml, p=0.045) and IFN-γ (69.82 pg/ml, p=0.005) were detected in the whole group of hepatitis. Active HCV hepatitis presented a significant increase in LL37 level (155.15±78.84ng/ml, p=0.014) and Th1 response by comparison with inactive HCV hepatitis. Conversely active HBV patients displayed low LL37 levels (76.75ng/ml, p=0.009) and no Th1 dominant response by comparison with inactive B hepatitis. High levels of LL37 up to 171.01±72.08 ng/ml and a moderate Th1 response defined HDV patients. Our results highlights increased levels of the cathelicidin LL37 in all viral hepatitis correlated with a strong and concordant immune response in active HCV hepatitis. , the key cytokine of T helper cell type 1 (Th1) response. The role of LL37 in viral hepatitis inflammation is unknown. We assessed the serum variations of LL37 and the Th1 response in hepatitis C virus (HCV), hepatitis B virus (HBV) and hepatitis D virus (HDV) infections. The LL37 level (Elisa detection) and Th1 response (defined by IFN-γ level, CD4+ and CD8+ T cell count) were analyzed in 87 patients: 65 hepatitis patients (34 HCV, 18 HBV, 13 HDV) and 22 healthy controls. The subjects, 33 males/ 54 women aged 20-64 years, were selected at "Matei Bals" Institut, Bucharest, Romania. Hepatitis patients were classified according to viral etiology and viral replication as active cases (detectable viremia) versus negative cases (undetectable viremia). Student T test and Mann Whitney analysis were applied. High levels of LL37 (138.09±88.45ng/ml, p=0.045) and IFN-γ (69.82 pg/ml, p=0.005) were detected in the whole group of hepatitis. Active HCV hepatitis presented a significant increase in LL37 level (155.15±78.84ng/ml, p=0.014) and Th1 response by comparison with inactive HCV hepatitis. Conversely active HBV patients displayed low LL37 levels (76.75ng/ml, p=0.009) and no Th1 dominant response by comparison with inactive B hepatitis. High levels of LL37 up to 171.01±72.08 ng/ml and a moderate Th1 response defined HDV patients. Our results highlights increased levels of the cathelicidin LL37 in all viral hepatitis correlated with a strong and concordant immune response in active HCV hepatitis.

Keywords

  • Cathelicidine LL37
  • Th1 response
  • viral hepatitis

Cuvinte cheie

  • Cathelicidina LL37
  • răspuns Thl
  • hepatite virale

Pianifica la tua conferenza remota con Sciendo